期刊文献+

甲磺酸加替沙星葡萄糖注射液与左氧氟沙星注射液治疗细菌性感染临床疗效观察 被引量:1

A randomized comparative study of gatifloxacin and levofloxacin injection in the treatment of bacterial infections
下载PDF
导出
摘要 目的 :评价国产甲磺酸加替沙星葡萄糖注射液治疗呼吸道感染及泌尿道感染的疗效与安全性。方法 :2 5例患者接受甲磺酸加替沙星葡萄糖液 2 0 0mg ,静脉滴注 ,每日 2次 ;2 5例接受左氧氟沙星注射液 2 0 0mg ,静脉滴注 ,每日 2次 ,疗程 5~14天。结果 :试验组和对照组痊愈率和有效率分别为 6 4 %、5 6 % (P >0 .0 5 )与 92 %、88% (P >0 .0 5 )。两组的细菌阳性率、消除率分别为 96 %、10 0 %和 6 8%、10 0 %。临床分离的 4 1株致病菌对甲磺酸加替沙星、左氧氟沙星、环丙沙星、司帕沙星、头孢噻肟的敏感率分别为 10 0 %、95 .12 %、95 .12 %、92 .6 8%、97.5 6 % ,无显著性差异 (P >0 .0 5 )。两组不良反应发生率分别为30 .77%和 2 0 % ,无显著性差异 (P >0 .0 5 )。结论 :甲磺酸加替沙星葡萄糖液治疗中、重度细菌感染安全。 Objective:To evaluate the clinical efficacy and safety of gatifloxacin injection in the treatment of moderate and severe bacterial infections.Methods:25 patients in study group were treated with gatifloxacin 200mg iv q12h and 25 patients in control group with levofloxacin 200mg iv q12h for 5 to 14 days.Results:The cure rates and the effective rates of the two groups were 64%,56%(P>0.05) and 92%,88%(P>0.05),respectively.The bacterial positive and eradication rates of the two groups were 96%,68% and 100%,100%,respectively.Sensitivity rates of 41 bacterial strains to gatifloxacin,levofloxacin,ciprofloxacin,sparfloxacin,cefataxime were 100%,95.12%,92.68%,97.56%,respectively.Adverse events were generally mild.Adverse events rates of the two groups were 30.77% and 20%(P>0.05),respectively.Conclusion:Gatifloxacin injection is a highly effective and well tolerated antibacterial agent for the treatment of moderate and severe bacterial infections.
出处 《重庆医科大学学报》 CAS CSCD 2004年第4期482-485,共4页 Journal of Chongqing Medical University
关键词 甲磺酸加替沙星 左氧氟沙星 临床疗效 细菌性感染 Gatifloxacin Levofloxacin Clinical trial Bacterial infections
  • 相关文献

参考文献5

  • 1许铁男.新喹诺酮类抗菌剂AM1155[J].国外医药(抗生素分册),1998,19(4):302-305. 被引量:22
  • 2杜煜,郭惠元.广谱、高效、低毒的新喹诺酮类抗菌药加替沙星[J].国外医药(抗生素分册),2001,22(1):34-39. 被引量:112
  • 3Banemfeind. A Comparison of the antibacterial activities of the quinolones Bay12 - 8039, gatifloxacin (AM1155),trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin[J]. J.Antimicrob Chemother, 1997; 40: 639 - 651.
  • 4Piddock LV,Johnson M, Ricci V, et al. Activities of new fluoroquinolones against fluoroquinolone- resistant pathogens of the lower respiratory tract [J]. Antimicrob Agents Chemother,1998; 42 (11): 2956 - 2960.
  • 5Wakabayashi E, Mitsuhashi S. In vitro antibacterial activity of AM- 1155, a novel 6 - fluoro- 8 - methoxy quinolone[J]. Antimicrob Agents Chemother, 1994 ;38(3) :594 - 601.

二级参考文献32

  • 1副岛林造.Gatifloxacin(GFLX)の概要[J].日本化学疗法学会杂志,1999,47(2):1-1.
  • 2柴孝也.健康成人におけゐgatifloxacinの体内动态に及ほす水酸化ろルミニウム及びシメジンの影响[J].日本化学疗法学会杂志,1999,47(S-2):218.
  • 3柴孝也.健康成人におけゐgatifloxacinの体内动态に及ぼす铁剂の并用,びに绿茶またば牛乳によゐ服药の影响[J].日本化学疗法学会杂志,1999,47(S-2):224.
  • 4(文)藤笃,中山一朗,大道光秀,他.内科领域感染症に对すゐgatifloxacin の前期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):260.
  • 5(文)藤笃,大道光秀,荒川正昭,他.呼吸器感染症に对すゐgatifloxacinの后期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):277.
  • 6河田幸道,熊本悦明,折笠精一,他.泌尿器科领域感染症に对すゐgatifloxacinの前期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):292.
  • 7河田幸道,熊本悦明,折笠精一,他.泌尿器科领域感染症に对すゐgatifloxacin の后期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):308.
  • 8由良二郎,岩井重富,中村阳一,他.外科领域におけゐgatifloxacinの基础的,临床的检讨[J].日本化学疗法学会杂志,1999,47(S-2):323.
  • 9荒田次郎,神崎宽子,石桥康正,他.皮肤科领域におけゐgatifloxacinの基础的,临床的检讨[J].日本化学疗法学会杂志,1999,47(S-2):338.
  • 10松田静治,千村哲朗,平山寿雄,他.产妇人科领域におけゐgatifloxacinの基础的,临床的检讨[J].日本化学疗法学会杂志,1999,47(S-2):351.

共引文献129

同被引文献57

引证文献1

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部